Ann: Remestemcel-L for COPD Published in Respiratory Research, page-54

Hi Praetorian,

I hope all be good mate... But really the ann didnt came as a financially change, means they could not even qualify this info relevant for the point of view of market...probably because not even for the scientific point of view..
Im not "non sayer man... Im supportive of the MSB but i dislike absolutely this report.Yes..im 100% ignorant in medical area and no level to judge,but so many paragraphs stressing NON EFFICACY that obviously for a amateur like me sounds the REM-L didn't impressed so much...The worst is the smal area where they looks good than they say,,,.yes but need more works to see if its correct or npot... Obvious this gives zero confidence...
Not matches with ann that paint much rosie scenario.
CATO